NCT03288610View on ClinicalTrials.gov

Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions
Systemic Inflammatory Response Syndrome (SIRS)Postoperative Vasodilation SyndromeStress ResponseCardiac Surgery PrognosisTissue Oxygenation and Post-ischemic Response
Interventions
DIAGNOSTIC_TEST

Preoperative copeptin level

Measure of plasmatic copeptin from preoperative samples retained in a biorepository. Physicians are blinded to the result.

Trial Locations (1)

34295

Department of critical care, Arnaud de Villeneuve Hospital, Montpellier

All Listed Sponsors
collaborator

Thermo Fisher Scientific, Inc

INDUSTRY

lead

University Hospital, Montpellier

OTHER

NCT03288610 - Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level | Biotech Hunter | Biotech Hunter